OZEM vs. LABD ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Direxion Daily S&P Biotech Bear 3X Shares (LABD)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$27.32
Average Daily Volume
31,803
14
LABD
Direxion Daily S&P Biotech Bear 3X Shares
LABD Description
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.Grade (RS Rating)
Last Trade
$5.76
Average Daily Volume
15,699,334
79
Performance
Period | OZEM | LABD |
---|---|---|
30 Days | -0.27% | -3.36% |
60 Days | -5.30% | 6.17% |
90 Days | 3.02% | -9.66% |
12 Months | -75.44% |
OZEM Underweight 75 Positions Relative to LABD
Symbol | Grade | Weight | |
---|---|---|---|
EXEL | A | -1.91% | |
BMRN | F | -1.89% | |
BLUE | F | -1.87% | |
VRTX | D | -1.84% | |
SAGE | F | -1.8% | |
UTHR | A | -1.78% | |
ALNY | C | -1.73% | |
EXAS | A | -1.73% | |
ABBV | A | -1.72% | |
ACAD | F | -1.68% | |
SRPT | D | -1.66% | |
BIIB | F | -1.65% | |
IONS | F | -1.64% | |
GILD | A | -1.64% | |
NBIX | C | -1.62% | |
BPMC | C | -1.61% | |
INCY | A | -1.51% | |
RARE | D | -1.49% | |
MRNA | F | -1.47% | |
LGND | A | -1.46% | |
ARWR | F | -1.45% | |
BHVN | B | -1.42% | |
PTCT | B | -1.4% | |
FOLD | B | -1.38% | |
AGIO | B | -1.37% | |
APLS | F | -1.24% | |
ALKS | F | -1.21% | |
MYGN | F | -1.08% | |
NTRA | B | -1.08% | |
IOVA | B | -1.07% | |
FGEN | F | -1.05% | |
RGNX | F | -1.05% | |
CHRS | F | -0.99% | |
EBS | B | -0.96% | |
CDNA | D | -0.93% | |
HRTX | F | -0.84% | |
INSM | D | -0.81% | |
KPTI | C | -0.79% | |
ESPR | C | -0.79% | |
ALLK | B | -0.76% | |
IRWD | F | -0.75% | |
VCYT | A | -0.72% | |
HALO | B | -0.71% | |
FATE | F | -0.67% | |
EDIT | F | -0.66% | |
PBYI | C | -0.65% | |
MDGL | A | -0.59% | |
TGTX | A | -0.55% | |
ADVM | D | -0.55% | |
ALLO | D | -0.54% | |
CPRX | A | -0.53% | |
ANAB | F | -0.53% | |
XNCR | A | -0.49% | |
SGMO | A | -0.48% | |
ENTA | D | -0.47% | |
EGRX | F | -0.42% | |
GTHX | A | -0.42% | |
ATRA | C | -0.41% | |
ANIK | F | -0.37% | |
VNDA | D | -0.35% | |
VCEL | D | -0.34% | |
TVTX | B | -0.33% | |
KOD | B | -0.29% | |
BBIO | D | -0.29% | |
NTLA | F | -0.29% | |
PGEN | F | -0.29% | |
DNLI | C | -0.28% | |
KRYS | C | -0.28% | |
GOSS | F | -0.27% | |
VYGR | C | -0.26% | |
MGNX | C | -0.25% | |
ALEC | D | -0.25% | |
CYTK | F | -0.25% | |
DVAX | A | -0.24% | |
YMAB | A | -0.24% |
OZEM: Top Represented Industries & Keywords
LABD: Top Represented Industries & Keywords